146 related articles for article (PubMed ID: 37030635)
1. Mutant p53 activates hnRNPA2B1-AGAP1-mediated exosome formation to promote esophageal squamous cell carcinoma progression.
Feng R; Yin Y; Wei Y; Li Y; Li L; Zhu R; Yu X; Liu Y; Zhao Y; Liu Z
Cancer Lett; 2023 May; 562():216154. PubMed ID: 37030635
[TBL] [Abstract][Full Text] [Related]
2. PRIMA-1 induces p53-mediated apoptosis by upregulating Noxa in esophageal squamous cell carcinoma with TP53 missense mutation.
Furukawa H; Makino T; Yamasaki M; Tanaka K; Miyazaki Y; Takahashi T; Kurokawa Y; Nakajima K; Takiguchi S; Mori M; Doki Y
Cancer Sci; 2018 Feb; 109(2):412-421. PubMed ID: 29168598
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA-Low Expression in Tumor inhibits the invasion and metastasis of esophageal squamous cell carcinoma by regulating p53 expression.
Wang PL; Liu B; Xia Y; Pan CF; Ma T; Chen YJ
Mol Med Rep; 2016 Apr; 13(4):3074-82. PubMed ID: 26935396
[TBL] [Abstract][Full Text] [Related]
4. Paired box 5 increases the chemosensitivity of esophageal squamous cell cancer cells by promoting p53 signaling activity.
Zhang W; Yan W; Qian N; Han Q; Zhang W; Dai G
Chin Med J (Engl); 2022 Feb; 135(5):606-618. PubMed ID: 35191417
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA LINC01088 inhibits esophageal squamous cell carcinoma progression by targeting the NPM1-HDM2-p53 axis.
Liang F; Luo Q; Han H; Zhang J; Yang Y; Chen J
Acta Biochim Biophys Sin (Shanghai); 2023 Mar; 55(3):367-381. PubMed ID: 36942988
[TBL] [Abstract][Full Text] [Related]
6. P53-regulated lncRNA uc061hsf.1 inhibits cell proliferation and metastasis in human esophageal squamous cell cancer.
Yao J; Zhang H; Li H; Qian R; Liu P; Huang J
IUBMB Life; 2020 Mar; 72(3):401-412. PubMed ID: 31743955
[TBL] [Abstract][Full Text] [Related]
7. Novel oncogenic transcriptional targets of mutant p53 in esophageal squamous cell carcinoma.
George SA; Kotapalli V; Ramaswamy P; Kumar R; Gowrishankar S; Uppin SG; Bashyam MD
J Cell Biochem; 2024 Apr; 125(4):e30534. PubMed ID: 38358025
[TBL] [Abstract][Full Text] [Related]
8. Mutant TP53 G245C and R273H promote cellular malignancy in esophageal squamous cell carcinoma.
Kang N; Wang Y; Guo S; Ou Y; Wang G; Chen J; Li D; Zhan Q
BMC Cell Biol; 2018 Aug; 19(1):16. PubMed ID: 30126368
[TBL] [Abstract][Full Text] [Related]
9. microRNA-377 acts as a suppressor in esophageal squamous cell carcinoma through CBX3-dependent P53/P21 pathway.
He Z; Chen J; Chen X; Wang H; Tang L; Han C
J Cell Physiol; 2021 Jan; 236(1):107-120. PubMed ID: 33459391
[TBL] [Abstract][Full Text] [Related]
10. CircCNTNAP3-TP53-positive feedback loop suppresses malignant progression of esophageal squamous cell carcinoma.
Wang H; Song X; Wang Y; Yin X; Liang Y; Zhang T; Xu L; Jiang F; Dong G
Cell Death Dis; 2020 Nov; 11(11):1010. PubMed ID: 33239613
[TBL] [Abstract][Full Text] [Related]
11. Anterior gradient 2 regulates cancer progression in
Takabatake K; Konishi H; Arita T; Kataoka S; Shibamoto J; Furuke H; Takaki W; Shoda K; Shimizu H; Yamamoto Y; Komatsu S; Shiozaki A; Fujiwara H; Okamoto K; Otsuji E
Oncol Rep; 2021 Dec; 46(6):. PubMed ID: 34713298
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA BCAR4 aggravated proliferation and migration in esophageal squamous cell carcinoma by negatively regulating p53/p21 signaling pathway.
Yan S; Xu J; Liu B; Ma L; Feng H; Tan H; Fang C
Bioengineered; 2021 Dec; 12(1):682-696. PubMed ID: 33602031
[TBL] [Abstract][Full Text] [Related]
13. LTBP1 promotes esophageal squamous cell carcinoma progression through epithelial-mesenchymal transition and cancer-associated fibroblasts transformation.
Cai R; Wang P; Zhao X; Lu X; Deng R; Wang X; Su Z; Hong C; Lin J
J Transl Med; 2020 Mar; 18(1):139. PubMed ID: 32216815
[TBL] [Abstract][Full Text] [Related]
14. EIF3H promotes aggressiveness of esophageal squamous cell carcinoma by modulating Snail stability.
Guo X; Zhu R; Luo A; Zhou H; Ding F; Yang H; Liu Z
J Exp Clin Cancer Res; 2020 Aug; 39(1):175. PubMed ID: 32867821
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of fibulin-4 inhibits autophagy and promotes the sensitivity of esophageal squamous cell carcinoma cells to apatinib by activating the Akt-mTOR signaling pathway.
Chen X; Wang J; Song L; Yu Y; Shi M; Jiang W; Liu X; He X
Thorac Cancer; 2022 Sep; 13(18):2592-2605. PubMed ID: 35950373
[TBL] [Abstract][Full Text] [Related]
16. CSMD1 suppresses cancer progression by inhibiting proliferation, epithelial-mesenchymal transition, chemotherapy-resistance and inducing immunosuppression in esophageal squamous cell carcinoma.
Wang X; Chen X; Liu Y; Huang S; Ding J; Wang B; Dong P; Sun Z; Chen L
Exp Cell Res; 2022 Aug; 417(2):113220. PubMed ID: 35623420
[TBL] [Abstract][Full Text] [Related]
17. Transgelin promotes ferroptosis to inhibit the malignant progression of esophageal squamous cell carcinoma.
Chen Q; Zhang L; Wan C; Yang B; Kong X; Xu X; Gu Y; Wang C; Liu X; Ding Q; Zhu L; Li Y; Wang B; Zhong W
Int J Oncol; 2023 Jul; 63(1):. PubMed ID: 37203411
[TBL] [Abstract][Full Text] [Related]
18. ATF3 functions as a novel tumor suppressor with prognostic significance in esophageal squamous cell carcinoma.
Xie JJ; Xie YM; Chen B; Pan F; Guo JC; Zhao Q; Shen JH; Wu ZY; Wu JY; Xu LY; Li EM
Oncotarget; 2014 Sep; 5(18):8569-82. PubMed ID: 25149542
[TBL] [Abstract][Full Text] [Related]
19. TP53 Mutations in Esophageal Squamous Cell Carcinoma.
Zhong L; Li H; Chang W; Ao Y; Wen Z; Chen Y
Front Biosci (Landmark Ed); 2023 Sep; 28(9):219. PubMed ID: 37796679
[TBL] [Abstract][Full Text] [Related]
20. IL-11 activated by lnc-ATB promotes cell proliferation and invasion in esophageal squamous cell cancer.
Yang SM; Li SY; Hao-Bin Y; Lin-Yan X; Sheng X
Biomed Pharmacother; 2019 Jun; 114():108835. PubMed ID: 30954889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
